SUMMARY-To determine the identity of the active carcinogenic metabolite in the urine of dogs given aromatic amines, we compared the metabolism of 1-naphthylamine and 2-naphthylamine in this species and found some of the following differences. 1) While 2-naphthylamine is metabolized to a unique diester [di(2-amino-1-naphthyl)phosphate], 1-naphthylamine is metabolized to a monophosphate ester of 2-amino-1-naphthol. 2) While 2-naphthylamine is metabolized exclusively to ortho-hydroxy conjugates, 1-naphthylamine is largely metabolized to para-hydroxy conjugates. 3) While both amines are N-hydroxylated, 2-naphthylamine is further oxidized to 2-nitrosonaphthalene. This further N-oxidative step does not appear to occur with the more stable N-1-naphthylhydroxylamine. The highly carcinogenic 4-aminobiphenyl is also metabolized to both the N-hydroxy and nitroso compounds. Experience has shown that the female beagle dog is the most suitable animal for testing bladder carcinogenic compounds.-J Nat Cancer Inst 43: 263-269, 1969.
EVIDENCE WAS presented as early as 1934-37 that the dog appeared to be the most suitable experimental animal for the screening of aromatic amines for bladder tumorigenic action. These studies were the initial attempts to determine the causative agent(s) of the so-called "aniline tumors" found in some dye workers (1) . Conducted under the direction ofW. C. Hueper, the studies included the administration of aniline, benzidine, and 1-naphthylamine and 2-naphthylamine by various routes to mice, rats, guinea pigs, rabbits, and female mongrel dogs. 2 2-Naphthylamine was proved to be a bladder carcinogen in the dog, while in the various rodents all 4 compounds were demonstrated to be noncarcinogenic.
With reference to the choice of an experimental animal for testing a compound for bladder carcinogenicity, Hueper (2) recently commented:
The known species specificity of chemical carcinogens and the distinct influence of species factors upon the target organ in which they may display their action determine to an important degree the outcome of bioassays performed on chemicals to be introduced into the human economy. Adequate ex- 1 These studies were supported in part by Public Health Service research grant CA 05449 from the National Cancer Institute. 2 One of us (Wm. B. D.) was a junior member of the team that investigated these compounds during 1934-37 at the Haskell Laboratory of Industrial Toxicology, E. I. DuPont de Nemours & Company, Inc., Wilmington, Del.
perience with this experimental screening method has shown that the dog represents the species of choice in testing aromatic amino-and nitro-compounds for carcinogenic properties to the bladder of man because dogs seem to metabolize these chemicals into products identical with or similar to those produced by man. This fact accounts also for the far reaching identity between the histopathologic character of the preneoplastic, precancerous and cancerous lesions observed in the bladder of man and dog exposed to these urinary carcinogens.
Multiparous mongrel bitches were used for the Haskell Laboratory studies. However, during recent years most investigators in Great Britain and in our laboratory have preferred female beagle dogs. The dogs in our studies were from 6 to 12 months old at the initiation of an experiment, and were bred in our laboratory from a registered stock of beagles. Comparison of the data of Walpole et aZ. (3) and ours (4, 5) suggested that tumors might be more readily produced in beagles than in mongrel dogs. We now believe, however, that factors such as dosage, solubility, and rate of absorption of a compound are probably more important. We contend that the diet also is a significant factor; diet influences absorption of an experimental compound, and it may also influence the tumorigenic action of the compound. In our experiments of the past 15 years, our dogs were fed Purina Kibble meal supplemented with a small quantity of canned horsemeat.
Aromatic amines were dissolved in corn oil and given in capsule form I hour before feeding time, at approximately 09:00 (on an essentially empty stomach). We find this method, which tends to reduce gastroenteric irritation and improve absorption, to be superior to administering the undissolved substance. It is difficult to determine the actual dose ingested when a test compound is given in the diet. Subcutaneous or intramuscular administration, by bypassing the portal circulation, may alter the metabolism of the compound.
The dosage is important. To determine the carcinogenicity of a compound, the highest tolerable dose should be administered-one that will not cause the chronic intoxication or death of the animal before bladder tumors have had time to develop.
The The purity of the compound to be subjected to long-term study must be carefully considered. Obviously, if the purpose of the investigation is to determine the carcinogenicity of a material in industrial use, then this impure commercial product should be used. Conversely, the highly purified chemical must be tested before any statement can be made on the carcinogenicity of the compound itself.
Only a few compounds have shown correlation in the production of bladder tumors in both man and dog-namely, certain aromatic amines. That this correlation exists is undoubtedly due to a close similarity in the metabolism of these amines in man and dog. However, metabolic studies have presented no proof that in general the dog metabolizes exogenous compounds with any greater similarity to man than do other experimental species. Therefore, it is well to keep in mind that compounds other than aromatic amino and nitro compounds may be metabolized alike in man, rat, and monkey-justification for including. the ra t and monkey in screening studies for carClllOgenesis. For example, N-[ 4-( 4-nitro-2-furyl)-2-thiazolyl]formamide produced tumors in the urinary bladder of the rat (7), while according to Conzelman there is ". . . reason to believe that chronic administration of pure 2-nitronaphthalene may induce tumors in the bladder of the rhesus monkey" (8) .
Dogs must be kept in clean, well-ventilated quarters. Recent observations in our laboratory indicate that several carcinogenic aromatic amines are partially excreted unmetabolized in the urine. Therefore, conceivably an appreciable amount of these compounds may be volatilized, contaminating the atmosphere, so that over a period of years, bladder cancer could be produced in dogs not receiving a carcinogenic compound.
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The primary handicap of the dog test procedure is that, as a rule, at least 2 years of testing are necessary to establish that a substance is carcinogenic. Obviously, the financial outlay for such a study limits the number of animals to be used. Fortunately, disadvantages are offset partially by the ease of maintaining a dog in good health for as long as 10 years and by the extremely low incidence of spontaneous bladder cancer in untreated dogs. We consider an experiment conclusive if a test substance administered to 4 dogs produces tumors in each of these animals within 2-4 years. Conversely, if the compound in an acceptable dose is administered to 4 or 5 dogs for 8-10 years but produces no tumors, then we judge the compound to be noncarcinogenic. As a rule, we administer a test compound to female beagle dogs for 6 years.
The question of an additive or synergistic effect among bladder carcinogens is both practical and important. In one 3-year experiment, we looked for such an effect with the combination of 4-nitrobiphenyl and 2-naphthylamine. Each compound was administered in a dose of 0.1 g 3 times a week. Although not conclusive, the results suggested that these compounds, in the dosage fed, were additive in carcinogenic action (9) . In another experiment designed to test the additive effects of 4 compounds-4-aminobiphenyl, 2-naphthylamine, 4-nitrobiphenyl, and benzidinethe dose of each was reduced to a level at which we expected none would individually produce bladder tumors. This was achieved with only 3 compounds: 4-nitrobiphenyl, 2-naphthylamine, and benzidine. 4-Aminobiphenyl produced tumors in each of 6 female beagle dogs given the surprisingly low daily dose of 1 mg/kg/dog, administered 5 times a week for 35 months (table 1) (10). This experiment revealed no evidence of an additive effect.
Reference has been made to cystoscopy. Visual inspection of the bladder mucosa during an experiment is desirable, particularly if the investigator wishes to discontinue administration of a test compound when local changes become evident.
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Years ago our dogs were cystoscoped once a year. Since we have come to believe that it is difficult to cystoscope a dog without a certain amount of trauma and since we are not certain that this is totally without effect in the development of tumors, we now practice cystoscopy only at the start of an experiment and, depending on the compound being tested, once every 3, 4, or 5 years. Our dogs are observed daily for signs of hematuria, and the urine is tested once a month for occult blood by use of the benzidine test. Every second month cytologic smears are prepared from the urine according to the Papanicolaou technique. The animals are cystoscoped when any of these observations is positive.
In 1954, McDonald and Lund unequivocally demonstrated that a substance in the urine produces cancer of the urinary bladder in the dog (13) . To determine the identity of this urinary constituent, we have compared the metabolism of 2-naphthylamine with l-naphthylamine, in the hope of finding a metabolite unique for 2-naphthylamine. Our goal was to account for all activity in the urine of dogs treated with these l4e-labeled amines.
The labeled amine was given to dogs. The urine was collected by catheter whenever possible and was sequentially extracted with three solvents of increasing polarity: ether, ethyl acetate, andafter saturation-with ammonium sulfate, tertbutyl alcohol (table 2) . By this procedure, virtually all the radioactivity was extracted from the urine. The ether extraction was performed in the dark immediately after collection; the ether extract was chromatographed on silica gel G by thin-layer chromatography (TLC) using benzene-acetone (8: 1) . In this extract, we obtained the unconjugated metabolites which are very sensitive to decomposition. The other two extracts, chromat- ographed by TLC using a more polar solvent system, contained largely the sulfate and glucuronide conjugates of the hydroxylated amine. Table 3 depicts the results of this procedure applied to the urine of dogs dosed with 2-naphthylamine. The discovery that 2-acetylaminofluorene is metabolized to N-hydroxy-2-acetylaminofluorene-a locally active carcinogen and apparently the active metabolite of the carcinogenic aromatic amine-led to speculation that the active carcinogen of 2-naphthylamine is an N-hydroxy compound. Free 2-naphthylhydroxylamine in the urine of dogs given large doses of this aromatic amine was demonstrated originally by Troll and Nelson (14) and later by Boyland and co-workers (15), and was confirmed by both an electrophoresis procedure developed in this laboratory and by TLC (16) . However, this finding was not consistent in all dogs of these three laboratories. Only a small percentage of the dogs tested were found to excrete N,2-naphthylhydroxylamine in the urine-in contrast to the observation that all dogs given 2-naphthylamine develop bladder cancer. 2-Nitrosonaphthalene in the urine has been demonstrated in this and other laboratories (17) . A unique metabolite discovered by Troll and associates (18) in the urine of dogs given 2-naphthylamine is a diester of 
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Residue phosphoric acid and two molecules of 2-amino-lnaphthol. Of course, most 2-naphthylamine is excreted as the sulfate of 2-amino-I-naphthol, as reported by Wiley in 1938 (19) . We were impressed, however, with the considerable amount of free amine in the dog urine, and have discovered that this is not a spillover from the administration of a large quantity used in an attempt to detect the presence of trace metabolites, as might be supposed. Free amine, seen even at minimal carcinogenic doses, may occur as a breakdown of the N-glucuronide which we found to be present. (table 4) . The results reveal a number of interesting similarities as well as contrasts to 2-naphthylamine. Since l-naphthylamine has an open para-position on the aromatic ring, hydroxylation occurs preferentially at this site. However, any theoretic significance attached to this observation is discounted by the appreciable quantities of the sulfate and glucuronide conjugates of the O-hydroxyamine also excreted. Workers in our laboratory first demonstrated that l-naphthylamine is also N-hydroxylated by the dog. Substantial quantities of the N-hydroxy compound were found in the urine (20) . That N-hydroxylation seems to be a universal reaction of aromatic amines was reported by Troll et at. (21) . Despite an intensive search, we were unable to demonstrate the presence of the phosphate diester of l-amino-2-naphthol, analogous to 2-naphthylamine. However, we did discover the presence of a monophosphate ester of l-amino-2-naphthol. Although the N-hydroxy derivate is present, we did not detect the nitroso compound. We also studied the metabolism of 4-aminobiphenyl in the dog. Chromatography of the 3 urine extracts obtained from dogs given maximally tolerated doses of 4-aminobiphenyl shows an intriguing simplicity. As observed many years ago, the bulk of the amine was metabolized to 4-amino-3-hydroxybiphenyl sulfate ester. In agreement with the N-hydroxylation theory, the urine of dogs given 4-aminobiphenyl, the most active bladder carcinogen, contains the N-hydroxy and nitroso metabolites (22) .
Obviously, one cannot identify the carcinogenic urinary metabolite or metabolites by metabolism studies alone. The ideal test procedure would utilize the bladder mucosa of the dog. This we attempted by weekly irrigation, via catheter, of dog bladders with dimethysulfoxide solutions containing some of these suspected carcinogenic substances (table 5 ). This extremely tedious experiment unfortunately produced no positive results. Several dogs were lost with cystitis and pyelonephritis. Simultaneously, we have been using more feasible test procedures. These metabolites were injected subcutaneously into newborn mice that were killed 14 months later and examined for tumors (table 6). In this experiment 2-naphthylhydroxylamine was more carcinogenic than l-naphthylhydroxylamine. This observation was consistent with the hypothesis that, although both l-naphthylamine and 2-naphthylamine may be Nhydroxylated, only 2-naphthylhydroxylamine is carcinogenic. Yet, according to Belman et at. (23) , 1-na ph th ylhydroxylamine, injected in traperi toneally into rats, is much more carcinogenic than 2-naphthylhydroxylamine. We are currently attempting to resolve this conflict by a more extensive study involving two strains of mice and also by a study in which we are injecting these materials intra peritoneally into rats, in a manner similar to that used in the experiment by Belman and Troll. We are also investigating the carcinogenicity of the two nitroso compounds. The N-oxidation of 2-naphthylamine is shown in text-figure 1. While 2-naphthylamine is metabolized to the nitro so compound, the N-oxidation of I-naphthylamine apparently stops at the Nhydroxy compound, which is much more stable than the N-hydroxy derivative of 2-naphthylamine. If, in our experiments, 2-nitrosonaphthalene should prove carcinogenic, we would have a tenable theory for the proximal carcinogen. After 30 years of investigation, the challenge remains: What is the active carcinogen of these aromatic amines? 
